Klinik Precious Me, Tangerang, Banten, Indonesia - 18 Mar `26Umbilical-cord cell secretome with light therapy for vitiligo

Umbilical-cord cell secretome with light therapy for vitiligo

Official title: Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study

Status: Opening soon

Description:

Yohanes Firmansyah, dr, MH, MM plans to enroll about 150 participants. This experimental treatment uses cell-derived particles and signaling proteins intended to change inflammation and tissue repair. Researchers hope these signals will protect melanocytes and encourage pigment to return. Possible risks include injection or infusion reactions, allergy, inflammation, infection, and other effects that are not yet known. People ages 18 to 60 may qualify. Recruitment has not started yet; the record lists one listed site in Indonesia.

Start date: March 18, 2026

Completion date: January 18, 2028

Organizer: Yohanes Firmansyah, dr, MH, MM

Contact: Sukmawati Tansil Tan, Dr.

Tel.: +62 878 711 113 18

Email: sukmawati@fk.untar.ac.id

Link: https://clinicaltrials.gov/study/NCT07509242

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Umbilical-cord cell secretome with light therapy for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions